US approves anal cancer vaccine

December 23, 2010

US health authorities have approved a vaccine intended to prevent anal cancer and pre-cancerous lesions in young people aged nine to 26 years old.

The (FDA) gave the green light Wednesday to the makers of the Gardasil, which is already used to treat women with cervical, vulvar, and vaginal cancer, and associated lesions caused by the human papillomavirus (HPV) types 6, 11, 16, and 18, officials said.

"Treatment for anal cancer is challenging; the use of Gardasil as a method of prevention is important as it may result in fewer diagnoses and the subsequent surgery, radiation or that individuals need to endure," said Karen Midthun, director of the FDA Center for Biologics Evaluation and Research.

Although anal cancer is rare in the general population, its occurence is increasing especially among gay men, officials noted.

The American Cancer Society estimates about 5,300 people are diagnosed with anal cancer each year in the United States, with more women diagnosed than men.

Related Stories

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

bhiestand
not rated yet Dec 23, 2010
Ugh, I hate everyone calling Gardasil a "cancer vaccine". It's an HPV vaccine. It works on these strains of HPV, whether anal or genital, right? So it's not a new drug, nor a cancer vaccine, nor approval of a new drug... it's just acknowledging that this drug also helps prevent anal infections of HPV 6, 11, 16, and 18, right?

The big news would be if they'd open this vaccine up to people older than 26.
banjo
not rated yet Dec 24, 2010
HPV16 is also implicated in Head and Neck cancers which have a 6:1 male preponderance.
USA and Swedish statistics show a new wave of these cancers in younger people and non-smokers.
H&N cancers are notoriosly difficult to detect as the primary stage, can be difficult to treat, and a nasty way to die.

My husband was diagnosed aged 47yrs and under went R) cevical node dissection, radiation 33 shots, and concurrent weekly chemo with cisplatin.

Re age of vaccination- ideally it is given before people are sexually active. Within the adult population, 50% have evidence of HPV exposure.
Of course I have had my teen son vaccinated, and my daughter has been vaccinated with free school program.

I hope in the future babies are immunised as infants, as for HepB. And for free (vs $500 Australian)
Wesleyfeng
not rated yet Dec 30, 2010
the United States Food and drug administration approved the usage of Gardasil, a human papillomavirus (HPV) vaccine, in the reduction of cervical cancer. Implementation fomented a yeast of dispute, as some states made vaccinations mandatory for girls as young as nine. Here is the proof: FDA approves use of Gardasil against anal cancer. Throw in a number of peculiar deaths some experts directly linked to the use of Gardasil and the FDA's decision was placed under scrutiny. Now the vaccine has formally joined up with the battle against anal cancer, reports CNN.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.